Skip to content

Reported July 31, 2025 · After market close

Next report

Aug 6, 2026 (In 3 weeks)

Financials

Q2 2025

Income statement

See full
Revenue$20.4M+56.1%
Gross profit$5.9M+57.1%
Operating income$1.9M+82.4%
Net income$2.7M+212%
EPS (diluted)$0.04+300%

Balance sheet

See full
Cash & equivalents$4.1M+74.2%
Total debt$10.7M-0.4%
Total equity$18.2M+52.5%
Total assets$60.0M+46.8%

Cash flow

See full
Operating cash flow-$654.0K-15.8%
CapEx$1.4M+195%
Free cash flow-$1.8M-72.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$364.54M
Enterprise value$371.14M
P/S5.7×

Profitability

See full
Gross margin28.1%+4.2pp
Operating margin8.3%+6.8pp

Returns & leverage

See full
Debt / equity0.6×-0.3×
Current ratio1.7×0.0×

Segments

By product

See full
Consumer Products$17.5M
Personal Care Ingredients$2.7M
Advanced Materials$128.0K

By geography

See full
Non Us$2.5M+427%

Versus estimates

Ask the moment Solesence, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Solesence, Inc. Common Stock report Q2 2025 earnings?
Solesence, Inc. Common Stock (SLSN) reported Q2 2025 earnings on July 31, 2025 after market close.
What were Solesence, Inc. Common Stock's Q2 2025 revenue and EPS?
Solesence, Inc. Common Stock reported revenue of $20.4M and diluted EPS of $0.04 for Q2 2025.
How did Solesence, Inc. Common Stock's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 56.1% from $13.0M a year earlier and diluted EPS grew 174.3% from $0.01.
Where can I find Solesence, Inc. Common Stock's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001999371-25-011366) directly on SEC EDGAR. The filing index links above go to sec.gov.